SARS-CoV-2: Virology, epidemiology, immunology and vaccine development

This first International Alliance for Biological Standardization Covid-19 webinar brought together a broad range of international stakeholders, including academia, regulators, funders and industry, with a considerable delegation from low- and middle-income countries, to discuss the virology, epidemi...

Descripción completa

Detalles Bibliográficos
Autores principales: Baay, Marc, Lina, Bruno, Fontanet, Arnaud, Marchant, Arnaud, Saville, Melanie, Sabot, Philippe, Duclos, Philippe, Vandeputte, Joris, Neels, Pieter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd on behalf of International Alliance for Biological Standardization. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7309765/
https://www.ncbi.nlm.nih.gov/pubmed/32600951
http://dx.doi.org/10.1016/j.biologicals.2020.06.005
_version_ 1783549255024115712
author Baay, Marc
Lina, Bruno
Fontanet, Arnaud
Marchant, Arnaud
Saville, Melanie
Sabot, Philippe
Duclos, Philippe
Vandeputte, Joris
Neels, Pieter
author_facet Baay, Marc
Lina, Bruno
Fontanet, Arnaud
Marchant, Arnaud
Saville, Melanie
Sabot, Philippe
Duclos, Philippe
Vandeputte, Joris
Neels, Pieter
author_sort Baay, Marc
collection PubMed
description This first International Alliance for Biological Standardization Covid-19 webinar brought together a broad range of international stakeholders, including academia, regulators, funders and industry, with a considerable delegation from low- and middle-income countries, to discuss the virology, epidemiology and immunology of, and the vaccine development for SARS-CoV-2.
format Online
Article
Text
id pubmed-7309765
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Published by Elsevier Ltd on behalf of International Alliance for Biological Standardization.
record_format MEDLINE/PubMed
spelling pubmed-73097652020-06-23 SARS-CoV-2: Virology, epidemiology, immunology and vaccine development Baay, Marc Lina, Bruno Fontanet, Arnaud Marchant, Arnaud Saville, Melanie Sabot, Philippe Duclos, Philippe Vandeputte, Joris Neels, Pieter Biologicals Article This first International Alliance for Biological Standardization Covid-19 webinar brought together a broad range of international stakeholders, including academia, regulators, funders and industry, with a considerable delegation from low- and middle-income countries, to discuss the virology, epidemiology and immunology of, and the vaccine development for SARS-CoV-2. Published by Elsevier Ltd on behalf of International Alliance for Biological Standardization. 2020-07 2020-06-23 /pmc/articles/PMC7309765/ /pubmed/32600951 http://dx.doi.org/10.1016/j.biologicals.2020.06.005 Text en © 2020 Published by Elsevier Ltd on behalf of International Alliance for Biological Standardization. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Baay, Marc
Lina, Bruno
Fontanet, Arnaud
Marchant, Arnaud
Saville, Melanie
Sabot, Philippe
Duclos, Philippe
Vandeputte, Joris
Neels, Pieter
SARS-CoV-2: Virology, epidemiology, immunology and vaccine development
title SARS-CoV-2: Virology, epidemiology, immunology and vaccine development
title_full SARS-CoV-2: Virology, epidemiology, immunology and vaccine development
title_fullStr SARS-CoV-2: Virology, epidemiology, immunology and vaccine development
title_full_unstemmed SARS-CoV-2: Virology, epidemiology, immunology and vaccine development
title_short SARS-CoV-2: Virology, epidemiology, immunology and vaccine development
title_sort sars-cov-2: virology, epidemiology, immunology and vaccine development
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7309765/
https://www.ncbi.nlm.nih.gov/pubmed/32600951
http://dx.doi.org/10.1016/j.biologicals.2020.06.005
work_keys_str_mv AT baaymarc sarscov2virologyepidemiologyimmunologyandvaccinedevelopment
AT linabruno sarscov2virologyepidemiologyimmunologyandvaccinedevelopment
AT fontanetarnaud sarscov2virologyepidemiologyimmunologyandvaccinedevelopment
AT marchantarnaud sarscov2virologyepidemiologyimmunologyandvaccinedevelopment
AT savillemelanie sarscov2virologyepidemiologyimmunologyandvaccinedevelopment
AT sabotphilippe sarscov2virologyepidemiologyimmunologyandvaccinedevelopment
AT duclosphilippe sarscov2virologyepidemiologyimmunologyandvaccinedevelopment
AT vandeputtejoris sarscov2virologyepidemiologyimmunologyandvaccinedevelopment
AT neelspieter sarscov2virologyepidemiologyimmunologyandvaccinedevelopment

Ejemplares similares